Erythema migrans (EM), persistent skin infection, and visceral dissemination can be induced reproducibly in the adult male New Zealand White rabbit by intradermal injection of as few as 103 Borrelia burgdorferL EM was found to persist for 7±3 d. Skin culture positivity (infection) cleared within a mean of 6.7±1.4 wk after infection and similarly visceral infection was not demonstrated after 8 wk; infection-derived immunit to intradermal challenge was evident 5 mo after initial infection. The extent of the protection against EM and dermal infection induced by untreated infection was directly related to
Introduction
Lyme borreliosis, the most common arthropod vector-borne disease in the United States (1) , is caused by the spirochete Borrelia burgdorferi sensu lato. In the majority of patients, an early manifestation of infection is the skin lesion, erythema migrans (EM)1 (2, 3) . These large, distinctive macular skin lesions may be uniformly erythematous, or "target" or "banded" in appearance. Histopathologically, EM is marked by perivascular infiltration of lymphocytes, macrophages, and plasma cells (4) . Early Lyme disease may also be characterized by spirochetal dissemination with subsequent involvement of joints, central and peripheral nervous systems, lymphoid tissue, and the heart. (2, (5) (6) (7) (8) .
There are a variety of rodent models, including rats (9, 10), mice (11, 12) , hamsters (13) (14) (15) , gerbils (16) , and guinea pigs (17) where B. burgdorferi can establish disseminated and chronic infection (10, 12, (15) (16) (17) . However, only in the rhesus monkey model has EM been reported (18) . Previous attempts to produce EM in the rabbit have not resulted in lesion formation from which B. burgdorferi has been isolated or which exhibit the characteristic histopathology of EM (19) (20) (21) However, polyarthritis and carditis, as well as dissemination of B. burgdorferi to spleen, kidney, brain, and joint have been reported for 3-wk-old American Dutch rabbits (22) .
In this study, using adult male New Zealand White rabbits, we report the reproducible induction of lesions with the appearance and histopathologic features of EM. B. burgdorfieri sensu stricto persists in the skin and disseminates to popliteal lymph nodes, stifle (knee) joints, and the spinal cord. Within a mean of 7 wk, infection is cleared from all cutaneous sites. Clearance of visceral infection was found to correlate closely with the clearance of dermal infection; no evidence of visceral infection was found after 8 wk. After clearance, rabbits exhibit immunity to intradermal (ID) challenge with virulent B. burgdorferi. Study of this infection-derived immunity enabled us to identify B. burgdorferi molecules of potential relevance to virulence and to induction of protective immunity in the rabbit. The rabbit model provides unique opportunities to study both the early events in the pathogenesis of Lyme borreliosis and the nature of infection-derived immunity.
Methods
Borrelia burgdorferi strains. Strains used and their respective sources are shown in Table I . Strains were grown at 34°C in 5 ml of BSK II medium (23) . When the cultures reached maximum density, 1.0 ml was passaged (subcultured) into 5 ml of fresh medium. Initial passage from tissue was designated "passage 0" and subsequent passages desig- 8 ,000 g and washed three times in normal rabbit serum which had been heat inactivated at 56°C for 30 min then diluted 1:1 in PBS, pH 7.2 (NRS-PBS). After each centrifugation and resuspension, spirochetal motility became less active; as a result, the spirochetes were allowed to sit at room temperature for 15 min to regain maximum motility. Organisms used as heat-killed controls were placed at 56°C for 45 min after the last wash. Concentrations of spirochetes were determined by darkfield visualization using a calibrated darkfield microscope. The inoculum was resuspended to the desired concentration after the last wash, and injected intradermally into the clipped backs of rabbits in 0.1-ml volumes. To visualize the site of inoculation throughout the course of the experiments, injections were always administered adjacent to a black dot made with a water-resistant laboratory marker.
Mouse infectivity of B31 strains. The B31 strain was shown to be infectious for 3-wk-old C3H/HeJ mice after 4,8, 27,47, and 85 passages in BSK II medium. Each of five mice per passage exhibited positive blood, ear, spleen, and/or bladder cultures obtained after intradermal inoculation of I03-I07 spirochetes by the methods described below. The infectivity of the 27, 47, and 85 passaged spirochetes is in contrast to the findings of other investigators (14, 24 Sera and adsorptions. Blood was obtained aseptically from the central artery of selected rabbits exhibiting different degrees of infectionderived immunity to challenge. The separated sera were frozen at -700C until ready for use. Adsorbed sera were obtained by incubating serum samples with aliquots of washed and frozen whole ATCC B31 and an acetone powder of the ATCC B31 strain prepared according to a method previously described (29) . Serum was adsorbed until reactivity with the ATCC B31 strain could not be detected at 1:600 dilution on enhanced chemiluminescence Western blots. Sequential absorptions with a total of 5 X 10'0 frozen whole organisms and 6 x 10'0 acetone organism equivalents were required to adsorb 750 iHl of serum. (30) . Significant differences were accepted at the P < 0.05 level.
Results
Induction of EM lesions in the rabbit by B. burgdorferi, strain B31. Initial studies with 36 adult New Zealand White rabbits showed that EM lesions resembling those seen in humans resulted from the ID injection of virulent strain B31 over a wide range of numbers of spirochetes passaged in vitro from 4 to 47 times. Table II Each of the 138 EM lesions resembled human EM. They appeared as either uniformly erythematous, banded, or target patterns; individual rabbits showed only one type of lesion pattern at each of the injection sites ( Histopathology ofEM in the rabbit. Histopathological studies were conducted on representative EM skin biopsy sections from rabbits infected with the B31 strain of B. burgdorferi.
Sections of skin from the lesion were stained with hematoxylin and eosin and examined microscopically. Examination at low power showed an intact keratinizing epithelium overlying dermis with infiltrating lymphocytic inflammatory cells in both the superficial and deep dermal layers (Fig. 2) . The infiltrate was diffuse in the superficial dermis. Inflammatory aggregates were more pronounced in the deep dermis, and deep inflammatory aggregates were especially prominent around adnexal structures, vessels, and small nerves. These deep inflammatory infiltrates produced an appearance of perivascular cuffing with extension of inflammation between and surrounding adjacent connective tissue bundles. When examined by high power, the infiltrate was a mixed lymphocyte population with occasional macrophages and plasma cells (Fig. 3) . Lymphocytes extended around small vessels leaving the endothelium largely intact. In areas of resolution, pyknosis and karyorrhexis of the inflammatory cells were apparent, without marked residual damage to surrounding structures.
Ability of additional B. burgdorferi strains to induce EM. Strains N40, SH-2-82, 297, HBl9, CA-2-87, and ECM-NY-86 were injected ID into four rabbits using 107 organisms per injection site. As shown in Table Im , five of the six strains Dissemination of strain B31 after intradermal injection. Tissues from 12 rabbits injected ID with 4 x 107 B31 passage 4 were cultured to determine the extent of visceral dissemination; two rabbits were killed at the timepoints specified in Table  IV A. B. burgdorferi was cultured from blood, spleen, liver, and heart at 24 h but could not be cultured from these tissues at later timepoints. Infection of the ear and popliteal nodes were first detected at 1 wk after infection and in the spinal cord at the 2-wk timepoint. Infection remained demonstrable at the 3- Figure 2 . Histopathology of rabbit erythema migrans. At X40 stained sections show diffuse lymphocytic infiltration of the superficial dermis. Lymphocytic aggregates are more prominent in deep dermal layers, especially around vessels and adenexa, producing an appearance of inflammatory cuffing. and 4-wk timepoints. Infection of the conjunctiva, stifle joint tissue, and synovial fluid was not determined before the 2-wk timepoint. However, each of these tissues was culture positive at 2 wk and joint tissue remained positive at 3 and 4 wk. Lung, kidney, bladder, cerebral cortex tissue, and cerebrospinal fluid was cultured at each timepoint and found to be consistently culture negative (data not shown). Rabbits were examined grossly for evidence of arthritis and found to have none. Hematoxylin and eosin-stained sections made from representative culture positive joints and spinal cords have not shown evidence of infiltrating cells or other evidence of inflammation.
The extent of dissemination to the lymph nodes, joint tissue, and spinal cord was also determined by culture during an 8-wk period after the intradermal inoculation of 10 rabbits with 6 X 103 B31 passage 4 (Table IV B) . At 2 wk after inoculation, 1, 4, 6, 8, 10 , and 12 wk from a site in proximity to the injection site. At 4, 6, 8, 10, and 12 wk, groups of three rabbits were killed for the determination of visceral infection. As shown in Fig. 4 , a progressive decrease of positive skin biopsies was observed from wk 4 to 12, at which time all of the animals had cleared the infection; the mean duration of infection was 6.7± 1.4 wk. Dissemination occurred 4-8 wk after infection but was not demonstrable at the 10-and 12-wk timepoints (data not shown). More evidence for the clearance of visceral infection is shown in the experiment described above (Table IV B) . In this experiment clearance of dissemination following the ID inoculation of 6 X 103 B31 passage 4 occurred by 8 wk after inoculation.
Dissemination of additional B. burgdorferi strains after intradermal injection. Dissemination studies similar to those conducted for the B31 strain were initiated with six additional strains utilizing two rabbits per strain. As shown in Table V, 4 wk after ID inoculation, at a time when the skin biopsy cultures were still positive, three of the six strains showed dissemination to the popliteal nodes and spinal cord; joint tissue of one of these strains and one additional strain were also culture positive. Strains CA-2-87 and ECM-NY-86 were not cultured from the viscera. Development of infection-derived immunity to strain B31. A study was designed to determine whether rabbits which had cleared EM and dermal infection with the B31 strain were immune to reinfection ( although 10 of 10 skin biopsy cultures were positive at the 7-, 21-, and 28-d timepoints; dissemination was not observed in these control animals. Rabbits challenged with ECM-NY-86 failed to develop lesions or dissemination. However, the failure to produce lesions at every site as well as the failure to observe dissemination in the control animals precludes any conclusion with respect to the ability of the ECM-NY-86 strain to produce infection-derived immunity.
Antibody response to infection and challenge. Potential quantitative differences in the antibody response of immune versus susceptible rabbits after infection and challenge with B. burgdorferi were determined by ELISA. The tests were conducted on prechallenge, 14-17 d postchallenge, and 28-35 d postchallenge sera obtained from 18 completely immune rabbits, 2 susceptible rabbits initially infected with passage 47 B3 1, and 6 control susceptible rabbits initially infected with the ATCC B31 or heat-killed low passage organisms. As shown in Fig. 6 , although each rabbit generated a primary and anamnestic antibody response to the whole organism, no significant correlation was observed between the titers and the status of immunity.
Immune serum defines antigens uniquely associated with virulent strain B31 and related to induction ofinfection-derived immunity. We hypothesized that the in vitro passage related differences in the ability of strain B31 to infect, to produce EM, and to induce different degrees of protective immunity described in the preceding sections might correspond to antigenic changes in B. burgdorferi. Norris has previously reported that 28-(OspD) and 35-kD lipoproteins are found in virulent strain B31, but are absent in the avirulent ATCC B31 strain (31) . To test if virulent B31 was antigenically distinct from less virulent and avirulent B31 (Table VI) , serum from a rabbit completely immune to infection with virulent strain B31 was adsorbed extensively with avirulent ATCC B31 strain as described in Methods. The immunoblot analysis shown in Fig. 7 B demonstrated that after extensive adsorbtions, only 19-and 35-kD proteins of avirulent ATCC B31 strain bound antibody (lane 4). In contrast, 70-, 55-, 35-, 32-, 28-, 19-, 18-, 17 .5-, and 15.5-kD antigens of B31 passage 1 were detected. B31 passage 27 lacked the 70-, 55-, and 17.5-kD antigens found in passage 1 but retained reactivity with the 35-, 32-, 28-, 19-, 18-and 15.5-kD proteins. Adsorbed antisera showed reactivity with antigens 38, 35, 33, 29, 27, 17.5, and 17 kD of the passage 47 isolate yet when compared to immunoblot protein profiles of the passage 1 and 27 isolates differed significantly in the intensity of the reactivity. These findings may relate to the differences in infectivity, ability to induce EM, and ability to induce protective immunity exhibited by different passages of B. burgdorferi strain B31, as shown in Tables II and VII. While the adsorbed antiserum used for these studies was derived from a single immune rabbit, we have obtained identical results using adsorbed serum obtained from a second immune rabbit when tested against low passage and the ATCC B31 strains.
It should be noted that none of the bands recognized with the adsorbed immune serum are OspA, as the OspA content of each of the passages of B31 was indistinguishable, equivalent numbers of spirochetes (5 x 107) were loaded per lane (Fig.  7 A) , and clearly no antigen is recognized in the molecular mass range of 31 kD in the ATCC B31 (Fig. 7 B, lane 4) . In addition, the adsorbed antiserum did not bind up to 5 1Lg of 
Discussion
This report demonstrates that infection of the New Zealand White rabbit with B. burgdorferi has unique features for the study of pathogenesis and immunity in Lyme borreliosis. The rabbit is very sensitive to infection with B. burgdorferi; intradermal injection of 103 B. burgdorferi low passage strain B31 is sufficient to reproducibly induce lesions characteristic of EM and chronic skin and visceral infection, including the knee joints and the central nervous system. Development of immunity to reinfection is a striking feature of the rabbit model. Within 3 mo after initial infection, both skin and visceral infection are cleared. 5 mo after the initial intradermal injection of 4 x 103 passage 4, strain B31, subsequent challenge with 4 X 10' passage 4 resulted in no dermal evidence of reinfection. It is interesting that progressive in vitro passage of strain B31 (to passage 47) does little to diminish its infectivity or ability to induce EM, but abrogates its ability to protect against reinfection. Each of these key facets of the model will be considered individually Although the production of EM and dissemination in the rhesus monkey has been reported (18) , the demonstration of EM in small animals such as rats (9, 10) , mice (11, 12) , hamsters (13) (14) (15) , gerbils (16) , and guinea pigs (17) ( 10, 12, (15) (16) (17) . The extent of the protective immunity induced by untreated infection was directly related to the extent of prior in vitro passage in the case of the B31 strain. Only B31, passage 4 was able to induce complete protection against EM and dermal infection with as few as 4 X 103 spirochetes. In contrast, initial infection with B31 passage 27 led to partial protection against EM together with complete protection against skin infection. B31 strain, passage 47 induced significantly less protection; there was no protection against skin infection, and partial protection against EM.
The above observations imply that certain determinants required for the production of protective immunity are being lost during in vitro passage. Identification of differences between B31 passages 4 and 47 may identify immunogens responsible for induction of complete protective immunity by passage 4. In studies relating to the identity of these protective immunogens, we found no distinction between the OspA content of passage 4 and passage 47 B31. Further, our studies utilizing ELISA showed no differences in anti-whole B. burgdorferi antibody levels between susceptible and immune rabbits. It is likely that potentially protective molecules represent a small fraction of the total protein antigens used in our ELISA analyses and may, therefore, be below the levels of detection and differentiation utilizing these assays.
In order that our findings may be viewed in the proper context, previous studies addressing differences between virulent and avirulent B. burgdorferi must be considered. Schwan and coworkers found that the plasmid profile of B. burgdoiferi strain SH-2-82 changes during in vitro passage and that certain plasmids are lost (24) . They also showed that the loss of plasmids correlated with a loss of infectivity for white-footed mice by in vitro passage 15.
In the present study we have found that B. burgdorferi, strain B31, retains infectivity for 3-wk C3H/HeJ mice at least up to in vitro passage 85. These differences in the preservation of mouse infectivity may relate to methods used for concentrating B. burgdorferi. In harvesting and washing cultures for infection of animals, as described in the Methods, the spirochetes were washed three times in heat-inactivated normal rabbit serum diluted 1:1 in PBS. After each centrifugation and resuspension, the spirochetes were allowed to sit at room temperature for 15 min to regain maximum motility. All spirochetes exhibited normal motility after this harvesting procedure. By comparison Schwan and coworkers reported resuspending the spirochetes in PBS without serum before infection of animals (24), which we feel may reduce motility and virulence of the spirochetes (Foley, D. M., M. A. Lovett, and J. N. Miller, unpublished observations).
In a study addressing compositional differences between virulent B31, passage 4-10, and the avirulent ATCC strain B31, Norris and his coworkers demonstrated that lipoproteins of 28 (OspD) and 35 kD are found in low passaged B. burgdorferi but not in ATCC B31 (31) . The gene for OspD is located on a 38-kbp linear plasmid which is present in the low passage strain but not in the ATCC B31 strain.
Our search for antigens related to in vitro passage induction of immunity Was based upon the development of an antibody reagent specific for virulent B. burgdorferi. This was accomplished by extensive adsorption of serum from a completely immune rabbit with the ATCC B31 strain. Our Western blot analysis of strain B31, passages 1, 27, 47, and the ATCC strain confirm and extend the observations of Norris with regard to the association of OspD and a 35-kD protein with virulence of this strain (31) . We found that 70-, 55-, 35-, 32-, 28-, 18-, 17.5-, and 15.5-kD antigens were detected in B31 passage 1 but absent in the ATCC B31 strain. We have confirmed that the 28-kD antigen is the outer membrane lipoprotein OspD which is absent both in passage 47 and in the ATCC B3 1 strain (Skare, J. T., E. S. Shang, D. M. Foley, D. R. Blanco, C. I. Champion, T. Mirabekov, Y. Sokolov, B. L. Kagan, J. N. Miller, and M. A. Lovett, manuscript in preparation). We have termed protein antigens found in virulent but not ATCC B3 1, "va", for virulent strain associated. While passage 27 and 47 lacked several va antigens found in passage 1, it is interesting to note that passage 47 had several va antigens, including 38, 33, 27, 17.5 and 17 kD, which appeared to be distinct in molecular mass from the va antigens of passages 1 and 27. Further, the 35-kD species observed in passage 47 and the ATCC B31 is not the early passage associated protein described above since this protein is absent in passage 47 as determined by two dimensional electrophoresis (Skare, The homologous challenge experiments with the B31 strain were based upon infection with a given passage but in every case involved subsequent intradermal challenge with B31 passage 4. We do not know if the in vitro passage related changes we have observed are reversible upon animal infection. To 
